|
|
|
|
CD8 T cells protect adult naive mice from JEV-induced morbidity via lytic function
|
|
|
|
|
|
|
|
نویسنده
|
jain n. ,oswal n. ,chawla a.s. ,agrawal t. ,biswas m. ,vrati s. ,rath s. ,george a. ,bal v. ,medigeshi g.r.
|
|
منبع
|
plos neglected tropical diseases - 2017 - دوره : 11 - شماره : 2
|
|
چکیده
|
Following japanese encephalitis virus (jev) infection neutralizing antibodies are shown to provide protection in a significant proportion of cases,but not all,suggesting additional components of immune system might also contribute to elicit protective immune response. here we have characterized the role of t cells in offering protection in adult mice infected with jev. mice lacking α/β–t cells (tcrβ–null) are highly susceptible and die over 10–18 day period as compared to the wild-type (wt) mice which are resistant. this is associated with high viral load,higher mrna levels of proinflammatory cytokines and breach in the blood-brain-barrier (bbb). infected wt mice do not show a breach in bbb; however,in contrast to tcrβ-null,they show the presence of t cells in the brain. using adoptive transfer of cells with specific genetic deficiencies we see that neither the presence of cd4 t cells nor cytokines such as il-4,il-10 or interferon-gamma have any significant role in offering protection from primary infection. in contrast,we show that cd8 t cell deficiency is more critical as absence of cd8 t cells alone increases mortality in mice infected with jev. further,transfer of t cells from beige mice with defects in granular lytic function into tcrβ-null mice shows poor protection implicating granule-mediated target cell lysis as an essential component for survival. in addition,for the first time we report that γ/δ-t cells also make significant contribution to confer protection from jev infection. our data show that effector cd8 t cells play a protective role during primary infection possibly by preventing the breach in bbb and neuronal damage. © 2017 jain et al.
|
|
|
|
|
آدرس
|
immunobiology,national institute of immunology,new delhi,india,sutterwala and cassel laboratory,cedars sinai medical center,los angeles,ca, United States, immunobiology,national institute of immunology,new delhi, India, immunobiology,national institute of immunology,new delhi, India, vaccine and infectious disease research centre,translational health science and technology institute,faridabad, India, immunobiology,national institute of immunology,new delhi,india,department of pediatrics,university of florida,gainesville,fl, United States, vaccine and infectious disease research centre,translational health science and technology institute,faridabad, India, immunobiology,national institute of immunology,new delhi,india,vaccine and infectious disease research centre,translational health science and technology institute,faridabad, India, immunobiology,national institute of immunology,new delhi, India, immunobiology,national institute of immunology,new delhi,india,vaccine and infectious disease research centre,translational health science and technology institute,faridabad, India, vaccine and infectious disease research centre,translational health science and technology institute,faridabad, India
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|